How Does the Interval Between Completion of Adjuvant Chemotherapy and Initiation of Radiotherapy Impact Clinical Outcomes in Operable Breast Cancer Patients? Lu CaoCheng XuJia-Yi Chen Breast Oncology 24 September 2020 Pages: 2155 - 2168
Surgical Outcomes of Mastectomy with Immediate Autologous Reconstruction Followed by Radiation Danielle R. HellerHaoran ZhuoBrigid K. Killelea Breast Oncology 24 September 2020 Pages: 2169 - 2179
ASO Author Reflections: An Evolving Approach to Autologous Reconstruction in the Setting of Postmastectomy Radiation Danielle R. HellerTomer AvrahamBrigid K. Killelea ASO Author Reflections 12 September 2020 Pages: 2180 - 2181
The Prognostic Value of Axillary Staging Following Neoadjuvant Chemotherapy in Inflammatory Breast Cancer Monica M. GrovaPaula D. StrasslePhilip M. Spanheimer Breast Oncology 24 September 2020 Pages: 2182 - 2190
Adjuvant Chemotherapy in Two-Stage Tissue Expander/Implant Breast Reconstruction: Does it Affect Final Outcomes? Kyeong-Tae LeeJuyoung BaeSa Ik Bang Breast Oncology 24 September 2020 Pages: 2191 - 2198
Oncoplastic Breast-Conserving Surgery: Can We Reduce Rates of Mastectomy and Chemotherapy Use in Patients with Traditional Indications for Mastectomy? Angelena CrownNicketti HandyJanie Grumley Breast Oncology 28 September 2020 Pages: 2199 - 2209
ASO Author Reflections: Oncoplastic Surgery Facilitates Breast Conservation and May Permit More Judicious Chemotherapy Use Angelena CrownFlavio G. RochaJanie Grumley ASO Author Reflections 15 September 2020 Pages: 2210 - 2211
Comparison of Multiple Wire, Radioactive Seed, and Savi Scout® Radar Localizations for Management of Surgical Breast Disease Marissa K. SrourSungjin KimAlice Chung Breast Oncology 28 September 2020 Pages: 2212 - 2218
Rapid Genetic Testing for BRCA1 and BRCA2 Mutations at the Time of Breast Cancer Diagnosis: An Observational Study Kelly A. MetcalfeAndrea EisenSteven A. Narod Breast Oncology 28 September 2020 Pages: 2219 - 2226
Landmark Series in Pancreatic Tumors: Anastomotic Techniques and Route of Reconstruction Teviah E. SachsJennifer F. Tseng Pancreatic Tumors 06 February 2021 Pages: 2227 - 2234
MicroRNA-593-3p Expression in Peritoneal Lavage Fluid as a Prognostic Marker for Pancreatic Cancer Patients Undergoing Staging Laparoscopy Tatsuo HataMasamichi MizumaMichiaki Unno Pancreatic Tumors 03 January 2021 Pages: 2235 - 2245
Total Neoadjuvant Therapy for Operable Pancreatic Cancer Rebecca Y. KimKathleen K. ChristiansSusan Tsai Pancreatic Tumors 30 September 2020 Pages: 2246 - 2256
Clinical Implication of Node-negative Resectable Pancreatic Cancer Mihoko YamadaTeiichi SugiuraKatsuhiko Uesaka Pancreatic Tumors 15 January 2021 Pages: 2257 - 2264
Does Major Pancreatic Surgery Have Utility in Nonagenarians with Pancreas Cancer? Rebecca S. MeltzerDavid A. KoobyMihir M. Shah Pancreatic Tumors 03 November 2020 Pages: 2265 - 2272
ASO Author Reflections: Chemoradiation as the Mainstay of Therapy for Nonagenarians with Pancreatic Cancer Rebecca S. MeltzerShishir K. MaithelMihir M. Shah ASO Author Reflections 01 January 2021 Pages: 2273 - 2274
ASO Visual Abstract: Does Major Pancreatic Surgery have Utility for Nonagenarians with Pancreas Cancer? Rebecca S. MeltzerDavid A. KoobyMihir M. Shah ASO Visual Abstract 07 January 2021 Pages: 2275 - 2276
Peritoneal Lavage Tumor DNA as a Novel Biomarker for Predicting Peritoneal Recurrence in Pancreatic Ductal Adenocarcinoma Masaya SuenagaTsutomu FujiiYasuhiro Kodera Pancreatic Tumors 01 September 2020 Pages: 2277 - 2286
Surgeon-Placed Continuous Wound Infusion Pain Catheters Markedly Decrease Narcotic Use and Improve Outcomes After Pancreatic Tumor Resection Lyonell B. KoneNicholas M. KundaAjay V. Maker Pancreatic Tumors 03 September 2020 Pages: 2287 - 2295
ASO Author Reflections: How Can We Improve the Postoperative Experience for Our Pancreatic Cancer Patients? A Practical Technique to Optimize Pain Control After Major Abdominal Surgery Ajay V. Maker ASO Author Reflections 10 September 2020 Pages: 2296 - 2298
Factors Influencing Exercise Following Pancreatic Tumor Resection Nathan H. ParkerKaren Basen-EngquistMatthew H. G. Katz Pancreatic Tumors 04 September 2020 Pages: 2299 - 2309
ASO Author Reflections: It is Time to Prioritize Exercise in Pancreatic Cancer Survivorship Nathan H. ParkerMatthew H. G. Katz ASO Author Reflections 04 September 2020 Pages: 2310 - 2311
Chemopreventive Agents After Pancreatic Resection for Ductal Adenocarcinoma: Legend or Scientific Evidence? Domenico TamburrinoGiovanni GuarneriMassimo Falconi Pancreatic Tumors 12 September 2020 Pages: 2312 - 2322
ASO Author Reflections: Chemopreventive Agents After Pancreatic Resection for Ductal Adenocarcinoma Domenico TamburrinoGiovanni GuarneriMassimo Falconi ASO Author Reflections 14 September 2020 Pages: 2323 - 2324
Impact of Borderline Resectability in Pancreatic Head Cancer on Patient Survival: Biology Matters According to the New International Consensus Criteria Friedrich AngerAnna DöringStefan Löb Pancreatic Tumors Open access 12 September 2020 Pages: 2325 - 2336
The Effect of Pancreatoduodenectomy Plus Intraperitoneal Hyperthermic Perfusion on Resectable Pancreatic Head Cancer: Cohort Study Feng FengXuehui CaoJianhua Liu Pancreatic Tumors 15 September 2020 Pages: 2337 - 2345
Novel Technique for Single-Layer Pancreatojejunostomy is Not Inferior to Modified Blumgart Anastomosis in Robotic Pancreatoduodenectomy: Results of a Randomized Controlled Trial Qu LiuZhiming ZhaoRong Liu Pancreatic Tumors 20 October 2020 Pages: 2346 - 2355
ASO Author Reflections: A Novel Technique for Single Layer Pancreatojejunostomy is not Inferior to Modified Blumgart Anastomosis in Robotic Pancreatoduodenectomy—Results of a Randomized, Controlled Trial Qu LiuRong Liu ASO Author Reflections 13 October 2020 Pages: 2356 - 2357
Modified Appleby Procedure, Distal Splenopancreatectomy with Celiac Axis Resection Haitham TrikiDamien BergeatLaurent Sulpice Pancreatic Tumors 21 October 2020 Pages: 2358 - 2358
The SSPN Score, a Novel Scoring System Incorporating PBRM1 Expression, Predicts Postoperative Recurrence for Patients with Non-metastatic Clear Cell Renal Cell Carcinoma Haruyuki OhsugiTakashi YoshidaTadashi Matsuda Urologic Oncology 17 September 2020 Pages: 2359 - 2366
Clinical Outcomes After Urinary Diversion for Malignant Ureteral Obstruction Secondary to Non-urologic Cancer: An Analysis of 778 Cases Ji Eun HeoDae Young JeonWon Sik Jang Urologic Oncology 02 January 2021 Pages: 2367 - 2373
Role of Node Dissection in Pancreatic Tumor Resection Mary DillhoffTimothy M. Pawlik Gastrointestinal Oncology 03 January 2021 Pages: 2374 - 2381
ASO Author Reflections: Role of Node Dissection in Pancreatic Tumor Resection Mary DillhoffTimothy M. Pawlik ASO Author Reflections 15 January 2021 Pages: 2382 - 2383
Evaluation of the Implementation of FDG-PET/CT and Staging Laparoscopy for Gastric Cancer in The Netherlands Emma C. GertsenAlicia S. Borggreveon behalf of the Dutch Upper Gastrointestinal Cancer Audit (DUCA) Group Gastrointestinal Oncology Open access 08 September 2020 Pages: 2384 - 2393
Association Among Blood Transfusion, Postoperative Infectious Complications, and Cancer-Specific Survival in Patients with Stage II/III Gastric Cancer After Radical Gastrectomy: Emphasizing Benefit from Adjuvant Chemotherapy Hua XiaoYanping XiaoGang Huang Gastrointestinal Oncology Open access 14 September 2020 Pages: 2394 - 2404
ASO Author Reflections: Association Between Perioperative Blood Transfusion, Infections, and Prognosis of Stage II/III Gastric Cancer Patients Hua XiaoJia Luo ASO Author Reflections 08 September 2020 Pages: 2405 - 2406
Risk of Lymph Node Metastasis and Feasibility of Endoscopic Treatment in Ulcerative Early Gastric Cancer Ren Ming-HanQi Xing-SiTian Zi-Bin Gastrointestinal Oncology Open access 25 September 2020 Pages: 2407 - 2417